Jilin Jian Yisheng Pharmaceutical Co Ltd (002566) — Tangible Net Worth Ratio
Jilin Jian Yisheng Pharmaceutical Co Ltd (002566) has a Tangible Net Worth Ratio of 95.4% as of March 2026. This metric is calculated by deducting intangible assets (CN¥108.13 Million) from net assets (CN¥2.35 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Jilin Jian Yisheng Pharmaceutical Co Ltd (002566) shareholders funds for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Jilin Jian Yisheng Pharmaceutical Co Ltd Tangible Net Worth Ratio (2006–2025)
This chart shows how Jilin Jian Yisheng Pharmaceutical Co Ltd's Tangible Net Worth Ratio has changed across 20 annual periods from 2006 to 2025. As of March 2026, the ratio stands at 95.4%, reflecting net assets of CN¥2.35 Billion with intangible assets of CN¥108.13 Million CNY. Also explore how fast is Jilin Jian Yisheng Pharmaceutical Co Ltd growing its equity to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Jilin Jian Yisheng Pharmaceutical Co Ltd (2006–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Jilin Jian Yisheng Pharmaceutical Co Ltd from 2006 to 2025, covering 20 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Jilin Jian Yisheng Pharmaceutical Co Ltd market capitalisation.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 95.3% | CN¥2.33 Billion | CN¥108.66 Million | CN¥2.96 Billion | ▲ +0.1 pp |
| 2024 | 95.2% | CN¥2.33 Billion | CN¥111.35 Million | CN¥2.97 Billion | ▲ +0.1 pp |
| 2023 | 95.1% | CN¥2.33 Billion | CN¥114.18 Million | CN¥3.05 Billion | ▲ +0.3 pp |
| 2022 | 94.8% | CN¥2.25 Billion | CN¥117.03 Million | CN¥2.97 Billion | ▲ +0.3 pp |
| 2021 | 94.5% | CN¥2.20 Billion | CN¥119.96 Million | CN¥2.86 Billion | ▲ +0.3 pp |
| 2020 | 94.2% | CN¥2.13 Billion | CN¥123.41 Million | CN¥2.80 Billion | ▼ -3.1 pp |
| 2019 | 97.3% | CN¥2.06 Billion | CN¥54.74 Million | CN¥2.50 Billion | ▲ +0.2 pp |
| 2018 | 97.2% | CN¥1.97 Billion | CN¥55.33 Million | CN¥2.55 Billion | ▲ +0.2 pp |
| 2017 | 97.0% | CN¥1.90 Billion | CN¥57.29 Million | CN¥2.65 Billion | ▲ +0.2 pp |
| 2016 | 96.8% | CN¥1.80 Billion | CN¥58.52 Million | CN¥2.67 Billion | ▲ +0.2 pp |
| 2015 | 96.6% | CN¥1.75 Billion | CN¥60.14 Million | CN¥2.63 Billion | ▼ -2.5 pp |
| 2014 | 99.1% | CN¥1.75 Billion | CN¥16.43 Million | CN¥2.49 Billion | ▲ +0.0 pp |
| 2013 | 99.0% | CN¥1.68 Billion | CN¥16.48 Million | CN¥1.89 Billion | ▲ +0.1 pp |
| 2012 | 98.9% | CN¥1.59 Billion | CN¥17.40 Million | CN¥1.66 Billion | ▼ -0.1 pp |
| 2011 | 99.0% | CN¥1.51 Billion | CN¥15.25 Million | CN¥1.58 Billion | ▲ +2.3 pp |
| 2010 | 96.7% | CN¥359.40 Million | CN¥11.77 Million | CN¥515.06 Million | ▲ +0.0 pp |
| 2009 | 96.7% | CN¥280.99 Million | CN¥9.22 Million | CN¥427.66 Million | ▼ -0.2 pp |
| 2008 | 96.9% | CN¥219.89 Million | CN¥6.82 Million | CN¥347.32 Million | ▲ +0.4 pp |
| 2007 | 96.5% | CN¥205.59 Million | CN¥7.27 Million | CN¥341.67 Million | ▼ -0.7 pp |
| 2006 | 97.1% | CN¥238.69 Million | CN¥6.83 Million | CN¥338.04 Million | — |